{
    "paper_id": "2324f5b1db825c2cf1a0d6db97830ea4435b072d",
    "metadata": {
        "title": "Supplemental Information Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice",
        "authors": [
            {
                "first": "Rudragouda",
                "middle": [],
                "last": "Channappanavar",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Anthony",
                "middle": [
                    "R"
                ],
                "last": "Fehr",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rahul",
                "middle": [],
                "last": "Vijay",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Matthias",
                "middle": [],
                "last": "Mack",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jincun",
                "middle": [],
                "last": "Zhao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "David",
                "middle": [
                    "K"
                ],
                "last": "Meyerholz",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Stanley",
                "middle": [],
                "last": "Perlman",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "week old BALB/c or Ifnar -/mice were intranasally infected with 1x 10 5 PFU of SARS-CoV. Mice were monitored for weight loss and survival. (B) 8-9 month BALB/c or Ifnar -/mice were intranasally infected with 100 PFU of SARS-CoV. Mice were monitored for weight loss and survival. (C-D) 7-9 week old BALB/c and Ifnar -/mice were monitored for weight loss and survival following MHV-1 (5x10 4 PFU/mouse, i.n.) (C) and PR8 (500 TCID50, i.n.) infection (D). These data represent 2 independent experiments with 4-6 mice/group. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "PerCp-Cy5.5-anti-IA/IE (M5/114.15.2), were procured from BD Biosciences or eBiosciences. APC/PE-anti-CCR2 (475301) was purchased from R&D systems",
            "authors": [
                {
                    "first": "Ifn-Beta",
                    "middle": [],
                    "last": "Antibodies",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Treatment",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "For surface/intracellular staining, cells were incubated with fluorochrome-labeled antibodies specific for mouse: BV510 or PECy7-anti-CD45 (30-F11) FITC-anti-Ly6G (1A8), PE/PerCp-Cy5.5-anti-Ly6C (AL-21), V450-anti-CD11b (M1/70)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "For monocyte depletion, anti-BST-2 antibody (Clone-X3TT, Bio X Cell: 200 \u00b5g/dose, i.p) or anti-CCR2 antibody (Clone: MC21, 25 \u00b5g/dose in 250 \u00b5l of PBS, i.p. (Mack et al., 2001) or control rat-IgG were administered at -6 hrs, day 1 and 2 p.i. Neutrophils were depleted using anti-Ly6G antibody (Clone: 1A8, 200\u00b5g/dose, i.p.) administered at -1, 1 and 3 dpi. For TNF neutralization",
            "authors": [],
            "year": null,
            "venue": "BALB/c mice were treated intraperitoneally (i.p.) with blocking monoclonal anti-IFN-I receptor (IFNAR) antibody (clone MAR1-5A3",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "BioLegend) or anti-TRAIL mAb (clone N2B2",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "BioLegend) was injected i.p. at 125 \u00b5g per mouse at days 1",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Cytokine and chemokine estimation: BAL fluid were prepared and analyzed for CCL2, TNF and IL-6 using mouse ELISA Ready-Set-Go kits (eBioscience). IFN-\u03b2 concentrations in BALF were measured using a Legend-Max mouse IFN-\u03b2 ELISA kit",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "RNA preparation from lungs and bone marrow cells and chemokine estimation by qPCR: RNA was extracted from the lungs of BALB/c and Ifnar -/-mice (Trizol, Invitrogen) or from bone marrow derived macrophages from na\u00efve BALB/c and Ifnar -/-mice stimulated for 24hrs with IFN-\u03b2 (500U/ml). mRNA levels were determined after normalizing each sample to HPRT. Specific primer sets used for qPCR were previously described",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Age and virus specific role for IFN-I. Related to Figure 1. (A) 7-9",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "IFN-I and IMMs promote vascular leakage in SARS-CoV infected lungs. Related to Figure 1 and 4. (A) 7-9 week old BALB/c, Ifnar -/and MC21 treated BALB/c mice were intranasally infected with 3 X 10 4 PFU of SARS-CoV. At day 5 p.i. mice were intravenously injected with Evans blue dye. After 30 minutes, mice were euthanized, perfused via right ventricle and lungs were collected for Evan's blue quantitation. (B-C) Quantification of Evan's blue from lungs of SARS-CoV infected BALB/c, Ifnar -/and MC21 treated BALB/c mice. These data represent 3-4 mice/group/experiment. Data in C are represented as +/-SEM. *P<0.05, **P<0.01 ***, Related to Figure 3 and 4. Young BALB/c and Ifnar -/mice were infected with 3X10 4 PFU of SARS-CoV (i.n.). (A) Graphs represent total number of innate immune cells in the lungs at different days p.i. Data are derived from 2 independent experiments with 4 mice/group/experiment. (B) Lung harvested from BALB/c and Ifnar -/mice were analyzed for CCR2 ligand (CCL2, CCL7 and CCL12) and GMCSF mRNA at indicated time points (4 mice/group). (C) IMMs harvested from lungs of SARS-CoV challenged BALB/c and Ifnar -/were analyzed for intracellular CCL2 expression at day 3 p.i. (3 mice/group). (D) Bone marrow derived macrophages were stimulated with IFN-\u03b2 (500U/ml) for 24 hrs and mRNA transcripts for CCR2 ligands were measured (3 mice/group). Data in B-D are represented as +/-SEM. *P<0.05, **P<0.01 ***, P < 0.001 Reduced pDC number and BALF cytokine levels in MC21 mAb treated mice. Related to Figure 3 and 4. Young BALB/c, Ifnar -/mice or MC21 antibody treated mice were intranasally inoculated with 3X10 4 PFU of SARS-CoV. (A-B) FACS plots and scatter plots show IMM depletion in Ifnar -/-, MC21 antibody treated lungs in comparison to BALB/c mice. (C) Bar graphs show pro-inflammatory cytokines and chemokine levels in BALF of control Ig and MC21 antibody treated BALB/c mice at day 3 PI. Graphs show mean +/-SEM of percentage cytokine/chemokine level. (D) FACS plots and scatter plot data show percentage and number of pDCs (CD11b -Ly6C + BST-2 + ) in control Ig and MC21 antibody treated mice. (E) Histograms show CCR2 expression on IMMs and pDCs (FACS plots). Data in C and D are represented as +/-SEM. *P<0.05, **P<0.01 ***, Mechanism of T cell apoptosis in SARS-CoV challenged mice. Related to Figure 6. (A-B) Flow cytometry analyses of FASL expression on IMMs and neutrophils and FAS on T cells (4mice/group). (D-E) Flow cytometry analyses of TRAIL on IMMs and neutrophils and DR5 on T cells (4 mice/group). (C) T cell apoptosis in control Ig treated versus anti-FASL treated mice (4 mice/group). (F) T cell apoptosis in control Ig treated versus anti-TRAIL treated mice (4 mice/group). (G) Flow cytometry analysis of intrinsic apoptosis molecule expression in T cells (3-4 mice/group). (H-I) Lung T cell apoptosis was measured in SARS-CoV challenged control Ig and anti-TNF treated mice at 5dpi, 3 mice/group, 2 independent experiments. Data in C, F, G and I are represented as +/-SEM. *P<0.05, **P<0.01 ***,",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}